Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Combined Peripheral and Central Treatments	52
Overall Study	STARTED	Peripheral Treatment	52
Overall Study	STARTED	Central Treatment	52
Overall Study	STARTED	Placebo	53
Overall Study	COMPLETED	Combined Peripheral and Central Treatments	40
Overall Study	COMPLETED	Peripheral Treatment	34
Overall Study	COMPLETED	Central Treatment	47
Overall Study	COMPLETED	Placebo	45
Overall Study	NOT COMPLETED	Combined Peripheral and Central Treatments	12
Overall Study	NOT COMPLETED	Peripheral Treatment	18
Overall Study	NOT COMPLETED	Central Treatment	5
Overall Study	NOT COMPLETED	Placebo	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03844412/flow